Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Replicel Life Sciences Inc V.RP

Alternate Symbol(s):  REPCF

RepliCel Life Sciences Inc. is a Canada-based regenerative medicine company. The Company is focused on developing cell therapies for aesthetic and orthopedic conditions, including aging/sun-damaged skin, pattern baldness, and chronic tendon degeneration. The Company’s cell therapy product pipeline is comprised of RCT-01 for tendon repair, RCS-01 for skin rejuvenation, and RCH-01 for hair restoration. RCH-01 is an autologous cell therapy utilizing dermal sheath cup (DSC) cells isolated from the hair follicle to treat androgenetic alopecia. RCS-01 is an autologous cell therapy utilizing non-bulbar dermal sheath (NBDS) cells, a type of fibroblast cell isolated from the hair follicle to repair and regenerate tissue. RCT-01 provides a source of collagen expressing cells to the site of injury, addressing the underlying cause of tendinosis. It has also developed an injection device, DermaPrecise, which improves the administration of its cell therapy products and certain other injectables.


TSXV:RP - Post by User

Post by bluemoons20on Sep 04, 2023 8:06am
156 Views
Post# 35618590

Where Are WE ??

Where Are WE ??On the surface  , 60  days  from  End of  May  should put us to  end of JUly.  And here we are at the end of  August  and still nothing!!

Do recall in some of the previous discussion there was mention of requests for 'post hearing briefs;  and some timeline associated with  those.  Also  , in the rules there is a line about agreement of the Parties.

So  if there is an extra month or two  due to this  , the decision SHOULD drop  right around the time of the AGM  ???


Overall  still feels like a long time  for the   process  - almost  2  years  until an actual  hearing??


If we started counting  from  May  this would not seem like too long a process  , but  really  , two years just to get to a hearing  in the first place??

GLTA

Hope the AGM  has all the answers  - Though  the insiders  could be more transparent on the timelines!!
<< Previous
Bullboard Posts
Next >>